Related by context. All words. (Click for frequent words.) 62 GV# [001] 62 Elagolix 61 TH# [003] 61 DB# [003] 61 radiation sensitizer 61 Archexin 61 liposomal formulation 61 metaglidasen 61 HuMax EGFr 60 KB# [002] 60 octreotide acetate 60 Exemestane 60 Sym# 60 proteasome inhibitor 60 mTOR inhibitor 60 pharmacodynamic properties 60 Erlotinib 60 selective modulator 60 Dasatinib 60 Tezampanel 59 Xanafide 59 CDK inhibitor 59 Carfilzomib 59 Safinamide 59 ZD# [001] 59 somatostatin analogue 59 Zolinza 59 EOquin TM 59 paclitaxel Taxol 59 SERMs 59 TLK# 59 modulators SERMs 59 Mipomersen 59 teriflunomide 59 ZOLINZA 59 generation purine nucleoside 58 vascular disrupting agent 58 Pertuzumab 58 solithromycin 58 reslizumab 58 SRT# [003] 58 Thiarabine 58 pan HDAC inhibitor 58 selectively binds 58 vascular disrupting agents 58 Protelos R 58 CCX# 58 PEGylated anti 58 PEG SN# 58 ARX# [001] 58 Ganciclovir 58 imatinib Gleevec ® 58 XYOTAX TM 58 elacytarabine 58 Vidaza azacitidine 58 Aliskiren 58 oral prodrug 58 mertansine 58 anticancer compound 58 PRO# [003] 58 R roscovitine 58 Maraviroc 58 Onconase 57 Hsp# Inhibitor 57 Raltegravir 57 aldehyde dehydrogenase ALDH2 deficiency 57 orally bioavailable 57 lapatinib Tykerb 57 Muraglitazar 57 Apoptone 57 Dapagliflozin 57 PDE4 inhibitor 57 Annamycin 57 anti angiogenic agent 57 tarenflurbil 57 Carvedilol 57 Boceprevir 57 Darunavir 57 Lenalidomide 57 Dabigatran etexilate 57 Ambrisentan 57 Panzem R 57 Tanespimycin 57 PEGylated Fab fragment 57 ENMD # 57 sorafenib Nexavar 57 Anticalin ® 57 VELCADE melphalan 57 subcutaneously administered 57 sargramostim 57 highly selective inhibitor 57 trodusquemine 57 polymerase inhibitor 57 PN# [001] 57 boosted protease inhibitor 57 Dalbavancin 57 cetuximab Erbitux 57 bazedoxifene selective estrogen receptor 57 EP# [003] 57 TAT# 57 TMC# [002] 57 selective androgen receptor modulator 57 Zoraxel TM 56 GW# [003] 56 elvitegravir 56 fosbretabulin 56 intranasal formulation 56 AZILECT R 56 Androxal TM 56 trospium 56 ALGRX 56 selective agonist 56 TRC# 56 Ixabepilone 56 orally dosed 56 sublingual formulation 56 HuMax 56 OncoVEX GM CSF 56 LAF# 56 TBC# 56 favorable pharmacokinetic profile 56 Aflibercept 56 trastuzumab Herceptin 56 Rotigotine 56 nitric oxide donating prostaglandin 56 axitinib 56 preclinical efficacy 56 TNF Tumor Necrosis Factor 56 TG# [003] 56 Afatinib 56 VA# [002] 56 AG# [003] 56 KN# [001] 56 aurora kinase 56 semisynthetic 56 vidofludimus 56 riociguat 56 Telmisartan 56 mTOR inhibitors 56 orally administered inhibitor 56 Everolimus 56 Interferon beta 56 Procoralan 56 ganetespib 56 DG# [003] 56 Tasimelteon 56 TRO# 56 LG# [002] 56 melphalan prednisone 56 selective estrogen receptor 56 Cloretazine VNP#M 56 PF# [002] 56 Azedra 56 Phase Ib clinical 56 Daclizumab 56 seliciclib CYC# 56 immunotherapeutic agent 56 Bucindolol 56 tumor xenograft models 56 Oral Fingolimod 56 Romiplostim 56 Vicriviroc 56 aripiprazole Abilify 55 Phase 1a clinical 55 Anticalin R 55 antiangiogenic activity 55 CYC# 55 dexpramipexole 55 CA4P 55 novel VDA molecule 55 Naproxcinod 55 Tyrima 55 RhuDex ® 55 XmAb# 55 Polymer Microspheres 55 nucleoside analog 55 Vandetanib 55 Vidaza R 55 AMN# [001] 55 Epratuzumab 55 IMA# 55 dopamine partial agonist 55 Abacavir 55 MYDICAR ® 55 RoACTEMRA 55 Traficet EN 55 volociximab 55 DXL# 55 TriRima 55 CCR5 antagonist 55 thalidomide Thalomid 55 angiogenesis inhibitor 55 Orally administered 55 Hycamtin ® 55 ALVESCO R 55 alvespimycin 55 BRIM2 55 2 methoxyestradiol 55 oral rivaroxaban 55 echinocandin 55 bexarotene 55 INT# [002] 55 Cloretazine 55 AS# amonafide L malate 55 dasatinib Sprycel ® 55 immunomodulatory therapy 55 HQK 55 cediranib 55 ASTEROID 55 GLP1 55 Panzem 55 TLR9 agonist 55 SGX# 55 mecamylamine 55 Fulvestrant 55 protein tyrosine phosphatase 1B 55 nucleoside analogue 55 Keppra XR 55 IRX 2 55 etanercept Enbrel 55 nebulized formoterol fumarate 55 E# E# [003] 55 sodium glucose cotransporter 55 corticosteroid dexamethasone 55 DUROS 55 Valsartan 55 INCB# [003] 55 PN# [003] 55 MYDICAR 55 Blinatumomab 55 crizotinib PF # 54 selective antagonist 54 phase IIb clinical 54 Genasense ® oblimersen 54 investigational integrase inhibitor 54 angiotensin receptor blocker ARB 54 Tesetaxel 54 tanespimycin 54 thrombin receptor 54 JAK inhibitor 54 Sitagliptin 54 proteasome inhibitor bortezomib 54 CIMZIA TM 54 SU# [003] 54 WP# [002] 54 ProSavin 54 Lubiprostone 54 Trastuzumab 54 Phase 2a Clinical Trial 54 nucleoside reverse transcriptase inhibitor 54 immunomodulator 54 Protelos 54 Pimavanserin 54 Aurora Kinase 54 LymphoStat B belimumab 54 Losartan 54 PI3K/Akt pathway inhibitor 54 Enkephalin 54 TREDAPTIVE 54 Bortezomib 54 entacapone 54 nucleotide analogue 54 APOPTONE 54 small molecule tyrosine 54 CTAP# Capsules 54 GAMMAGARD 54 GLYX 54 atazanavir Reyataz 54 diabetic neuropathic pain 54 Vidofludimus 54 EGFR HER2 54 uricase 54 Zoledronic acid 54 Eculizumab 54 ME# [002] 54 phase IIa clinical 54 MDV# 54 Eltrombopag 54 selective adenosine 54 anticancer agent 54 Voreloxin 54 PRT# 54 OXi# 54 HuLuc# 54 Intravenous CP 54 DFMO 54 systemically administered 54 Receptor Agonist 54 pertuzumab 54 ATL# [002] 54 INCB# [001] 54 EndoTAG TM -1 54 cetuximab Erbitux ® 54 epothilone 54 huC# DM4 54 Triolex 54 DNA intercalator 54 SGLT2 inhibitor 54 HDAC Inhibitor 54 THR beta agonist 54 modulator SERM 54 Temsirolimus 54 cholesteryl ester transfer 54 immunofluorescence staining 54 novel synthetic peptide 54 S/GSK# 54 evaluating tivozanib 54 potent inhibitor 54 Aptivus ® 54 palonosetron 54 Enzastaurin 54 NP# [002] 54 immune modulatory 54 inhibitor RG# 54 Zoloft sertraline 54 BN# [002] 54 PDX pralatrexate 54 CYT# potent vascular disrupting 54 xanthine oxidase inhibitor 54 Aplidin R 54 erlotinib Tarceva ® 53 LY# [003] 53 ND# [002] 53 Laquinimod 53 oral renin inhibitor 53 Preclinical studies suggest 53 Factor VIIa 53 dihydrochloride 53 rHuEPO 53 ZX# [001] 53 Tarvacin 53 tenofovir Viread 53 vivo validation 53 DACH platinum 53 Interferon alfa 53 rNAPc2 53 Elvitegravir 53 Angiocept 53 BRAF inhibitor 53 HMG CoA reductase inhibitors 53 CBLC# 53 bortezomib Velcade ® 53 BC# [003] 53 Perifosine 53 pioglitazone HCl 53 OMP #M# 53 neuroprotective properties 53 Fidaxomicin 53 Methylnaltrexone 53 NGX# 53 gefitinib Iressa 53 Mg Usa 53 cMET 53 ON #.Na 53 DG# [001] 53 CG# [001] 53 IFN α 53 FK# 53 Epivir 53 PV# [003] 53 GX# [001] 53 PNP inhibitor 53 ARC# [002] 53 fluticasone furoate 53 CYP#A# CYP#D# 53 VAPRISOL 53 RP# [002] 53 Oral NKTR 53 rFIXFc 53 docetaxel Taxotere ® 53 CG# [003] 53 Azacitidine 53 adalimumab Humira 53 protein kinase inhibitor 53 antisense oligonucleotide 53 R#/MEM # 53 epothilones 53 generation nucleoside analog 53 proteasome inhibitors 53 DP b# 53 Vilazodone 53 ISIS # 53 Candesartan 53 Tofacitinib 53 Ampakine 53 serotonin norepinephrine reuptake inhibitor 53 Preclinical studies 53 Debio 53 EP# [005] 53 receptor modulators 53 Nexavar sorafenib 53 Bruton tyrosine kinase Btk 53 Bicifadine 53 ED# [002] 53 investigational humanized monoclonal antibody 53 lumiliximab 53 Fenretinide 53 Sorafenib 53 Vaprisol 53 methionine aminopeptidase 53 direct renin inhibitor 53 visilizumab 53 SLx 53 Atrasentan 53 multitargeted 53 Elacytarabine 53 insulin sensitizers 53 Lisofylline 53 Fondaparinux 52 Angiotensin 52 MBX 52 CORT # 52 phase IIa 52 SNT MC# 52 receptor antagonists 52 Radezolid 52 Crizotinib 52 HCV replicon 52 Golimumab 52 Squalamine 52 dyskinesia PD LID 52 stable nucleic acid 52 Sapacitabine 52 ATL# [001] 52 SCH # 52 telomerase therapeutic 52 antiplatelet agent 52 CCR2 52 EOquin 52 renin inhibitor 52 Novel Oral 52 Tekturna HCT 52 PI3K inhibitor 52 ocular formulation 52 5 HT3 antagonist 52 insulin sensitizing 52 mGluR5 negative 52 mu opioid receptor antagonist 52 ESBA# 52 fluvastatin 52 NV1FGF 52 Recombinant Human 52 novel prodrug 52 Bosentan 52 AVE# 52 #mg dose [001] 52 Symadex 52 reversible inhibitor 52 AZD# 52 BAY #-# 52 cilengitide 52 Perindopril 52 NS# [003] 52 nucleoside analogues 52 ALK inhibitor 52 #ME# 52 SPC# [001] 52 elotuzumab 52 rivastigmine Exelon 52 MEK inhibitor 52 Ocrelizumab 52 RH1 52 #beta HSD1 52 Celecoxib 52 Cleviprex TM clevidipine 52 subcutaneous formulation 52 aromatase inhibitor AI 52 EZN 52 Aviptadil 52 endothelin receptor antagonists 52 Biolimus A9 52 mRNA antagonists 52 gamma secretase inhibitor 52 tyrosine kinase inhibitor 52 MoxDuo ® IR 52 Angiotensin Converting Enzyme 52 CX# [004] 52 pegfilgrastim 52 LX# [003] 52 XL# [003] 52 pioglitazone Actos 52 HE# [002] 52 allosteric modulator NAM 52 Liraglutide 52 LH RH 52 adipiplon 52 Elesclomol 52 hypoxia selective 52 Locked Nucleic Acid LNA 52 HemosIL 52 lurasidone 52 NN# [001] 52 R pioglitazone HCl 52 small molecule glucokinase 52 Latitude E# E# E# 52 RGB # 52 virus HCV protease inhibitor 52 rhIL 7 52 muscarinic 52 2DG 52 MEK inhibitors 52 PLX# 52 candesartan cilexetil 52 infliximab Remicade 52 cathepsin K inhibitor 52 PD# [005] 52 NXL# 52 esomeprazole Nexium 52 CD# monoclonal antibody 52 partial agonist 52 integrase inhibitor 52 histone deacetylase HDAC 52 TRIOLEX 52 tezampanel 52 non porcine pancreatic 51 Synavive 51 Ramelteon 51 Phenoptin 51 Linaclotide 51 potent inhibition 51 FT# [001] 51 DP4 51 FOLOTYN ® 51 paricalcitol 51 posaconazole 51 TELCYTA 51 anti amnesic 51 Coversyl 51 inhaled formulation 51 MKC# MKC# PP 51 C#T [001] 51 vascular disrupting 51 6R BH4 51 Phase 2a Study 51 amifampridine phosphate 51 JAK1 51 Atacand ® 51 Imprime PGG 51 albiglutide 51 JAK2 inhibitor 51 intensive lipid lowering 51 LY# [002] 51 erlotinib Tarceva 51 MAP# 51 MB# [004] 51 Interferon beta 1a 51 selective inhibition 51 oral proteasome inhibitor 51 ruxolitinib 51 NEUGENE 51 5 HT3 receptor 51 cortisol synthesis 51 drug conjugate 51 cangrelor 51 mineralocorticoid receptor 51 Cyclosporine 51 mGluR2 NAM 51 davalintide 51 Chemokine Receptor 51 signal transduction inhibitor 51 chimeric monoclonal antibody 51 canakinumab 51 levodopa carbidopa 51 radezolid 51 Nanobody 51 BENICAR HCT 51 Leukotriene 51 MCF7 51 administered subcutaneously 51 Didanosine 51 V#L 51 delta isoform 51 CEQ# 51 Proellex TM 51 SinuNase TM 51 cytidine 51 Byetta exenatide 51 Rilonacept 51 tafamidis 51 oxidative stress inducer 51 Adenoma Prevention 51 DU #b 51 CXB# 51 generation antisense 51 sphingosine 1 51 Rivaroxaban 51 sulindac 51 PRISTIQ 51 Abbokinase 51 receptor agonists 51 AT# [002] 51 GAP #B# 51 SLC# 51 IAP inhibitor 51 pharmacokinetic PK profile 51 TPI ASM8 51 Curaxin CBLC# 51 bucindolol hydrochloride 51 highly selective endothelin 51 Assay Kit 51 Rasagiline 51 AEG# 51 edifoligide 51 VP# [003] 51 Marqibo TM 51 cardioprotective effects 51 ADP receptor antagonist 51 MICARDIS 51 selective inhibitor 51 PF # [001] 51 Nanobody ® 51 Bavituximab 51 Glypromate 51 Vidaza ® 51 humanized monoclonal 51 SL# [004] 51 beta2 agonist 51 Catena ® 50 refractory gout 50 oral FTY# 50 MK# [003] 50 AT# [001] 50 SGLT2 inhibitors 50 HGS# 50 HCV protease inhibitor 50 thromboxane A2 50 BCX# 50 aprepitant 50 MDR1 50 inhibitor PPI 50 antifibrotic 50 PSN# [002] 50 HA# 50 eprotirome 50 Bendavia 50 XL# XL# XL# 50 COREG CR 50 LHRH antagonists 50 ELND-#/AZD-# 50 Soliris eculizumab 50 statin simvastatin 50 Cetrorelix 50 PEGPH# 50 antitumor efficacy 50 TRX# 50 olmesartan 50 idarubicin 50 Tenormin 50 OMNARIS 50 obatoclax 50 lamivudine zidovudine 50 COPAXONE 50 ELND# 50 virus AAV 50 Atripla efavirenz 50 Phase 2b clinical trials 50 CX# [002] 50 Trp p8 50 R#/MEM 50 pyridoxal 5' phosphate 50 receptor partial agonist 50 EPC# 50 KIF6 gene 50 investigational pan BCR 50 nucleotide analog 50 HuMax HepC 50 tiapamil 50 VRX# [002] 50 angiotensin II receptor 50 peripherally acting 50 fenofibric acid 50 Lisofylline LSF 50 CD# antibodies 50 Hsp# inhibitors 50 TLR7 50 vaccine GRNVAC1 50 lomitapide 50 IMiDs 50 iroxanadine 50 GRN#L 50 antiarrhythmic 50 HepDirect prodrug 50 Reductase 50 epigenetic therapies 50 receptor antagonist 50 catheter occlusion 50 Desmoteplase 50 Tolvaptan 50 Cyclooxygenase 2 50 allogeneic cell 50 Lpathomab 50 SB# chipset 50 cyclooxygenase 50 selectively inhibit 50 Ecallantide 50 investigational oral 50 HCV protease inhibitors 50 TAFA# 50 Zenvia Phase III 50 ubiquinone 50 LG# [001] 50 darunavir Prezista 50 proprietary polysaccharide 50 SO DIMM 50 8 pin MSOP 50 ALN TTR 50 TRV# [001] 50 PDGFR 50 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 50 Apixaban 50 ® pioglitazone HCl 50 CD3 monoclonal antibody 50 Onalta 50 C# C# [003] 50 PTP 1B 50 nucleoside polymerase inhibitor 50 rosuvastatin calcium 50 PRX # 49 potent topoisomerase II 49 tablet formulation 49 Aurora kinase 49 HCV protease 49 PARI Pharma GmbH 49 investigational compound 49 5 HT2C receptor 49 rHuPH# 49 dopamine agonist 49 investigational pharmacologically unique 49 ALS #-# 49 Sinemet 49 Hsp# inhibitor 49 GSK# [002] 49 Celebrex celecoxib 49 Progestin 49 MoxDuo 49 Factor Xa inhibitor 49 glatiramer 49 V# V# [001] 49 Akt inhibitor 49 KX2 49 TELINTRA 49 polymerase inhibitors 49 r hGH 49 Phase IIa trials 49 TM# [001] 49 PS# [001] 49 induces apoptosis 49 Sierra Wireless Aircard 49 Locteron 49 LX# LX# 49 NMDA antagonists 49 antithrombotic 49 Novatel Wireless Merlin 49 inhibitor rofecoxib 49 Anacetrapib 49 orally bioavailable mimics 49 Starlix 49 BIO SET 49 humanized monoclonal antibody 49 P#S 49 P#X# 49 anti angiogenic 49 Resten NG 49 hypercholesterolemia 49 humanized anti 49 novel topoisomerase 49 TNFa 49 SERCA2a 49 rilonacept 49 recombinant tissue plasminogen 49 exon skipping 49 PTP1B 49 Vascugel ® 49 kinase inhibitor 49 NET# [002] 49 T#I [002] 49 TNFα 49 Agilent #B [002] 49 myelofibrosis polycythemia vera 49 Spectrum Selective Kinase 49 Receptor Agonists 49 Atacand 49 laropiprant 49 pharmacokinetics PK 49 MLN# 49 DPP4 inhibitor 49 antisense drug 49 LTB4 49 renin inhibitors 49 PET# 49 teduglutide 49 Azixa 49 Deadlinepix 49 Solazed ™ 49 occlusion PAO 49 Deforolimus 49 HCV polymerase inhibitors 49 SARMs 49 DURECT proprietary 49 Myolimus 49 GS# [003] 49 AV# [001] 49 SIRT2 49 direct thrombin inhibitors 49 Cand5 49 IAP inhibitors 49 Durezol 49 bile acid sequestrant 49 E# [003] 49 Solazed TM 48 AA# [002] 48 investigational monoclonal antibody 48 Renin inhibitors 48 BL# [003] 48 cystic fibrosis transmembrane conductance 48 peroxisome proliferator activated 48 nalbuphine ER 48 PE# [001] 48 Survivin antagonist 48 SAMe 48 PLK1 SNALP 48 #D#C# 48 ADL# 48 ODNs 48 AR# [001] 48 Atripla combines 48 X# X# X# 48 TRX4 48 glucagon receptor 48 RTL# 48 Bruton tyrosine kinase 48 ularitide 48 trial evaluating PRX# 48 ALN TTR# 48 XOPENEX HFA 48 Levodopa 48 ADX# 48 lacosamide 48 HepDirect 48 insulin sensitizer 48 MTP inhibitor 48 Locteron ® 48 PI3K/mTOR 48 recombinant erythropoietin 48 Solulin 48 DU# [002] 48 sd rxRNA 48 alagebrium 48 GSK3B 48 cytokine interleukin 48 AX# [001] 48 Fluvastatin 48 G#A [001] 48 Shuttle XPC Barebone 48 opioid receptor antagonist 48 mild vasodilator 48 CCR9 antagonist 48 anti CD3 48 AZT zidovudine Retrovir 48 ALN PCS 48 velafermin 48 oral Janus kinase 48 prescribed proton pump 48 NS#/#A protease 48 UsiRNAs 48 oral anticoagulant 48 Darapladib 48 DE# [001] 48 familial amyloidotic polyneuropathy FAP 48 HER3 48 AT# [003] 48 SU# [002] 48 beta Estradiol 48 GRNCM1 48 acting basal insulin 48 TAKSTA 48 EPSON Stylus 48 tumor necrosis 48 PARP inhibitors 48 CYP #A# 48 phenelzine 48 #C# [003] 48 NNRTIs 48 HGS ETR1 48 RG# [001] 48 LNCaP 48 Gigabyte GSmart 48 Panasonic KX 47 TRILIPIX 47 ancrod 47 MEK inhibitor RDEA# 47 QX# [001] 47 receptor agonist 47 platinum chemotherapeutic 47 Rasilez ® 47 TRIOLEX ™ 47 Clusterin 47 Ivabradine 47 CD# CEA 47 antidiabetic drugs 47 PT# Pro 47 Microplasmin 47 drug eluting coronary stent 47 enzyme cofactor 47 PathVysion 47 FBPase 47 amikacin 47 E selectin 47 SELZENTRY 47 M2 subunit 47 MG# [002] 47 IX# [002] 47 BXT # 47 VEGFR2 47 Lacromin 47 tasocitinib 47 LPM TM 47 reverse transcriptase inhibitor 47 allosteric modulator 47 urothelium 47 LX# [002] 47 rosuvastatin #mg 47 Axona 47 GPIIb IIIa 47 Ticagrelor 47 MP# [001] 47 ApoB SNALP 47 MG# [003] 47 MSI P# GD# 47 Samsung SL# 47 acetylcholine receptor 47 XG# [001] 47 candidate Gencaro TM 47 MIVEC 47 IV bolus formulation 47 DDR3 modules 47 Xacti VPC 47 investigational drug 47 STV# 47 REP# 47 Toshiba Portege M# 47 oral antidiabetic medication 47 S#F [001] 47 REG1 47 Waters Xevo 47 VL# [002] 47 CD# antibody [001] 47 Samsung Tocco Ultra 47 GL# [003] 47 Edarbi 47 rFVIIIFc 47 EX# [002] 47 darapladib 47 ivabradine 47 HT# [002] 47 CMS# 47 deferiprone 47 lipid lowering therapies 47 XP# [003] 47 preclinical studies 47 oncolytic 47 thermosensitive 47 C#A [002] 47 HDACi 47 small molecule activators 47 APPRAISE 47 HepaLife PICM 47 oral Factor Xa 47 dihydrofolate reductase 47 DDR3 SO DIMM 47 Disease IBD 47 FVIIa 47 CXL 47 TNF α 47 propafenone 47 LPA1 receptor 47 mTOR kinase 47 calcineurin inhibitors 47 Model #A 47 selective inhibitors 46 RANK Ligand 46 V#i [001] 46 Fleximer 46 Caveolin 1 46 hypoxia inducible factor 46 Revascor TM 46 S#X [003] 46 AV# [003] 46 nForce4 46 A2 Lp PLA2 46 Ridaforolimus 46 HyACT 46 VNB# 46 NRTI 46 immunomodulation 46 KOMBIGLYZE XR 46 gatifloxacin 46 Zetia ezetimibe 46 serine protease